SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-10-050278
Filing Date
2010-05-17
Accepted
2010-05-17 14:54:16
Documents
5
Period of Report
2010-05-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K y84620e8vk.htm 8-K 24782
2 EX-2.1 y84620exv2w1.htm EX-2.1 334666
3 EX-4.1 y84620exv4w1.htm EX-4.1 19814
4 EX-99.1 y84620exv99w1.htm EX-99.1 13688
5 GRAPHIC y84620y8462001.gif GRAPHIC 6322
  Complete submission text file 0000950123-10-050278.txt   403518
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15190 | Film No.: 10837855
SIC: 2835 In Vitro & In Vivo Diagnostic Substances